Introduction {#s1}
============

The limbic system of the brain is a complex network of structurally and functionally linked anatomic regions ([@B1]). Among its components are areas in anteromedial temporal lobe including the amygdala, hippocampal complex, and entorhinal cortex, as well as the cingulate cortex. These areas are interconnected with each other via the thalamus (particularly the anterior thalamic and medial dorsal nuclear groups as well as the midline thalamic nuclear group), and project to the hypothalamus and midbrain, and anteromedial temporal lobe. The limbic system is an important component of the systems subserving emotion, behavior, and memory. In patients with medial temporal lobe epilepsy (mTLE), perturbations of the limbic system often result in in debilitating comorbidities and functional impairments in addition to the direct consequences of seizures.

The role of the limbic system in epilepsy is well-described, with mTLE frequently involving limbic structures and the pathological hallmark of hippocampal sclerosis ([@B2]--[@B4]). The limbic system\'s physiologic ability to produce and propagate synchronized activity during normal cognition makes the limbic system an ideal environment for the propagation of pathological synchronization during a seizure ([@B5]). Given the role of the limbic system in long-term recall and in emotion, it has been postulated that the high prevalence of memory, mood, and affective symptoms among patients with mTLE correlates with a disruption of normal limbic function ([@B5]--[@B7]).

Networks throughout the brain are altered in epilepsy. Network changes have been associated with cognitive decline, seizure onset zone locations, and surgical outcomes ([@B8], [@B9]). For example, increased thalamic "hubness" (the importance of a node in a network) prior to anterior temporal lobectomy surgery is associated with increased risk of seizure recurrence after surgery ([@B10]). Effective connectivity inferred by dynamical causal modeling has suggested that strengthened connectivity between the hippocampus and parahippocampal gyrus is associated with poor seizure control in TLE ([@B11]). Despite promising associations between limbic circuitry and clinical features, the contribution of limbic connectivity to actual seizure burden remains unclear.

To identify resting-state functional connectivity (RS FC) features associated with seizure frequency, we assessed limbic and temporal RS FC in mTLE patients and healthy controls. We used network-based statistics to identify functional connectivity abnormalities in the limbic system, and to find a relationship between those abnormalities and seizure frequency. By identifying the networks underlying clinical presentations of epilepsy, we may better target neuromodulatory approaches to the circuit components either potentiating or regulating epileptic networks.

Materials and Methods {#s2}
=====================

Participants and Clinical Scores
--------------------------------

Consecutive mTLE patients who underwent comprehensive epilepsy evaluations including EEG monitoring at the Mayo Clinic Epilepsy Center were identified from an epilepsy research database. Twelve patients (five females) with unilateral mTLE ([Table 1](#T1){ref-type="table"}) and 12 healthy control subjects ([Table 2](#T2){ref-type="table"}), matched to the mTLE subjects by age, gender, and handedness, were studied. The control subjects were free of neurological and psychological disease. All participants provided written, informed consent in accordance with research protocols approved by the institutional review board of Mayo Clinic. We collected the numbers of seizures per month during the 3 months preceding the MRI scan as a quantitative score of disease burden. Structural MRI data were reviewed for all subjects to assess for neuroradiological abnormalities. A board certified psychiatrist (PEC) retrospectively reviewed all clinical records to ascertain if subjects had a co-occurring psychiatric disorder. In mTLE group, there were 8 subjects with neuroradiological abnormalities and 9 subjects with psychiatric disorders.

###### 

Demographic information for participants with medial temporal lobe epilepsy (mTLE).

  **Subject index (*N* = 12)**   **Video-EEG diagnosis; seizure onset zone**   **Handedness**   **Age range (year)**   **Epilepsy duration (year)**   **Seizure frequency (number of seizures per months)**   **Neuroradiological abnormality in the structural MRI assessment**                                        **Psychiatric symptom**                                                          **Psychotropic medication**
  ------------------------------ --------------------------------------------- ---------------- ---------------------- ------------------------------ ------------------------------------------------------- --------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------- ---------------------------------
  01                             Right mTLE                                    Right            60--69                 50                             0.1                                                     None                                                                                                      Depression, Anxiety                                                              Citalopram
  02                             Left mTLE                                     Right            30--39                 16                             8                                                       None                                                                                                      Remote history of alcohol and cannabis abuse (8--10 years before presentation)   None
  03                             Left mTLE                                     Right            40--49                 42                             8                                                       Stable non-specific foci of increased T2/FLAIR signal in the subcortical left frontal lobe white matter   None                                                                             None
  04                             Right mTLE                                    Right            20--29                 28                             30                                                      Right mesial temporal sclerosis                                                                           Anxiety                                                                          Citalopram, sertraline
  05                             Left mTLE                                     Right            10--19                 16                             4                                                       None                                                                                                      Insomnia                                                                         Clonazepam
  06                             Left mTLE                                     Right            30--39                 32                             24                                                      Left hippocampal atrophy                                                                                  Depression, ADHD                                                                 Mixed amphetamine (Adderall XR)
  07                             Left mTLE                                     Right            20--29                 12                             3                                                       Mild leukoaraiosis                                                                                        Anxiety                                                                          None
  08                             Left mTLE                                     Left             20--29                 7                              2                                                       T2 hyperintensities suggestive of migraine                                                                Depression, nicotine-use disorder                                                Citalopram
  09                             Left mTLE                                     Right            20--29                 1                              20                                                      None                                                                                                      Nicotine-use disorder (smokeless tobacco)                                        None
  10                             Right mTLE                                    Right            50--59                 2                              3                                                       Right temporal encephalocele                                                                              None                                                                             None
  11                             Left mTLE                                     Left             20--29                 22                             1                                                       Left hippocampal atrophy                                                                                  None                                                                             None
  12                             Left mTLE                                     Right            30--39                 6                              16                                                      Nonspecific T2 hyperintensities                                                                           Anxiety                                                                          Alprazolam

*Twelve healthy control subjects were matched for age, sex, and handedness (N = 12, mean age difference = 0.00; p \> 0.99). The indirectly identifiable patient data (gender, exact age, exact seizure onset age) were removed according to editorial guidance*.

###### 

Demographic information for healthy control subjects (five females).

  **Subject index (*N* = 12)**   **Handedness**   **Age range (year)**   **Neuroradiological abnormality in the structural MRI assessment**   **Psychiatric symptom**   **Psychotropic medication**
  ------------------------------ ---------------- ---------------------- -------------------------------------------------------------------- ------------------------- -----------------------------
  01                             Right            50--59                 None                                                                 None                      None
  02                             Right            30--39                 None                                                                 None                      None
  03                             Right            40--49                 None                                                                 None                      None
  04                             Right            20--29                 None                                                                 None                      None
  05                             Right            10--19                 Possible pineal cyst                                                 None                      None
  06                             Right            30--39                 None                                                                 None                      None
  07                             Right            20--29                 None                                                                 None                      None
  08                             Right            20--29                 None                                                                 None                      None
  09                             Right            20--29                 None                                                                 None                      None
  10                             Right            50--59                 None                                                                 None                      None
  11                             Left             20--29                 White matter hyperintensities                                        None                      None
  12                             Left             20--29                 None                                                                 None                      None

Image Acquisition
-----------------

Anatomical and functional MRI images were acquired in all subjects on a Siemens 3T Magnetom Skyra system using a 32-channel array head coil and tetrahedron-shaped foam pads to minimize head movement. High-resolution structural whole-brain images were acquired using a T1-weighted sequence with 0.5 × 0.5 × 1.2 mm^3^ resolution, TR = 2.3 s, TI = 0.9 s, TE = 1.96 ms, and FA = 9°. Subjects were instructed to keep their eyes open during which resting-state (RS) functional magnetic resonance imaging (FMRI) data were acquired by using a gradient echo-planar sequence sensitive to blood oxygenation level-dependent contrast with 3.28 × 3.28 × 3.3 mm^3^ resolution, 50 slices, TR = 2.9 s, TE = 30 ms, FA = 90°, and total acquisition time of 464 s.

Preprocessing of Imaging Data
-----------------------------

Preprocessing of all imaging data was conducted using the Analysis of Functional NeuroImages (AFNI) software package (<http://afni.nimh.nih.gov>). The RS FMRI data were preprocessed and denoised by the standard protocol of the AFNI package ([@B12]--[@B14]). Using the robust non-linear warping function of the AFNI package, all T1 anatomy data were registered to the MNI152-T1-2009c atlas of the Montreal Neurological Institute and linearly resampled in the 1 mm isocubic grid space. The EPI data were aligned to the T1 images, and then warped to the template brain space along with their T1 images. The registration results for the image data of all subjects were visually inspected for subcortical and cortical brain structures[^1^](#fn0001){ref-type="fn"}. Note that the imaging data of three mTLE patients with seizure foci in the right hemisphere were left-right flipped before the preprocessing, to match the ipsi- and contra-lateral concept of the analysis. The terms "ipsilateral" and "contralateral" hemispheres stand, respectively for the hemisphere of seizure onset and the hemisphere opposite the side of seizure onset.

Functional Connectivity Analysis
--------------------------------

For the functional network analysis ([@B16], [@B17]), masks for regions-of-interest (ROIs) in the limbic system and temporal lobe structures were defined by multiple atlases ([@B18]--[@B21]), with reference to existing studies of animal seizure models and human patients ([@B22], [@B23]). The entire list of ROIs and the atlas details are presented in [Figure 1A](#F1){ref-type="fig"} and [Table 3](#T3){ref-type="table"}. The RS FMRI time series were separately averaged in each ROI mask, and then a Pearson correlation matrix between those was calculated as the network data of each individual subject (by a permutation test for 10,000 iterations with random network extents). A total of 253 RSFCs between ROI pairs were calculated for each subject. The group difference graph between healthy control and mTLE groups were also determined by a two-sample *t*-test with a threshold level at the family-wise-error-corrected *p* \< 0.01 ([@B16]).

![Functional connectivity results for regions of interest (ROIs) in the limbic system and temporal lobe. ROIs in limbic and temporal lobe areas were investigated using network-level analysis (also see [Table 3](#T3){ref-type="table"} for details on defining ROIs). **(A)** The graphical representation of functional networks in limbic and temporal lobe regions for the healthy controls (HC), derived by one-sample *t*-test to the zero mean with a threshold level at *p*~*FWER*−*corrected*~ \< 0.001. Circles connected by a line represent a pair of ROI nodes and their functional connection. Anatomical labels for the nodes (circles) are described in the upper right panel. **(B)** The graphical representation of functional networks in drug-resistant medial temporal lobe epilepsy (mTLE). The same statistical approach to panel A was applied. The mTLE patients showed decreased limbic functional connectivity relative to the HC group. The functional connectivity among limbic networks and temporal lobe regions, however, showed less change compared to intra-limbic connectivity changes. **(C)** Group difference between functional networks in HC and mTLE groups. A two-sample *t*-test was performed with a threshold level at *p*~*FWER*−*corrected*~ \< 0.01. The intra-limbic connectivity between ipsilateral hippocampus, subiculum, hypothalamus, mediodorsal thalamus, ventromedial prefrontal cortex (BA14), bilateral parahippocampal gyri, ventral anterior, dorsal and ventral posterior cingulate cortices, and contralateral dorsal anterior cingulate cortex are decreased in the mTLE group. **(D)** The functional networks significantly correlated with seizure frequency in mTLE patients at a threshold level of *p* \< 0.05. Functional connectivity between ipsilateral ventral anterior cingulate cortex and hypothalamus, and that between ipsilateral subiculum and contralateral ventral posterior cingulate cortex showed significant correlation with seizure frequency. The ROI pairs (circles) in limbic system, showing significant difference in functional connectivity between mTLE and HC groups are also summarized in the [Table 4](#T4){ref-type="table"}.](fneur-10-00488-g0001){#F1}

###### 

Definition of regions-of-interest (ROIs) in limbic structures and seizure-relevant areas for the network-level analysis.

  **ROI index**                                **Region**                               **Base atlas**   **Remarks**
  -------------------------------------------- ---------------------------------------- ---------------- -----------------------------------------------------------------
  **HIPPOCAMPAL FORMATION**                                                                              
  1                                            Hippocampus (Hp)                         FS-Hp            CA1, CA2, CA3, and CA4 were merged into one mask.
  2                                            Subiculum (Sb)                           FS-Hp            Subiculum, parasubiculum, and subsubiculum were merged.
  3                                            Hippocampal tail                         FS-Hp            
  **DIENCEPHALON**                                                                                       
  4                                            Anterior nuclei of thalamus              Morel-Th         Anterior dorsal, medial, and ventral nuclei were merged.
  5                                            Mediodorsal nucleus of thalamus (ThMD)   Morel-Th         Magnocellular and parvocellular mediodorsal nuclei were merged.
  6                                            Hypothalamus (Hth)                       FS-aseg          Hypothalamus is included in the inferior diencephalon mask.
  **SUBCORTEX**                                                                                          
  7                                            Amygdala                                 FS-aseg          
  **VENTROMEDIAL PREFRONTAL CORTEX (VmPFC)**                                                             
  8                                            Brodmann area 11m                        MNI-VmPFC        
  9                                            Brodmann area 14 (BA14)                  MNI-VmPFC        BA14c, BA14m, BA14r, and BA14rr were merged.
  **CINGULATE CORTEX**                                                                                   
  10                                           Dorsal anterior (dACC)                   MNI-VmPFC        Brodmann area 24
  11                                           Ventral anterior (vACC)                  MNI-VmPFC        Brodmann area 32
  12                                           Subgenual anterior (BA25)                MNI-VmPFC        Brodmann area 25
  13                                           Anterior middle                          FS-a2009s        
  14                                           Posterior middle                         FS-a2009s        
  15                                           Dorsal posterior (dPCC)                  FS-a2009s        
  16                                           Ventral posterior (vPCC)                 FS-a2009s        
  17                                           Subcallosal gyrus                        FS-a2009s        
  **OTHER CORTICAL AREAS**                                                                               
  18                                           Parahippocampal gyrus (Php)              FS-a2009s        
  19                                           Insula                                   FS-a2009s        
  20                                           Temporal pole                            FS-a2009s        
  21                                           Superior temporal gyrus/sulcus           FS-a2009s        
  22                                           Middle temporal gyrus                    FS-a2009s        
  23                                           Inferior temporal gyrus/sulcus           FS-a2009s        

*FS-HP, -aseg, -a2009s are FreeSurfer templates for hippocampal subfields, automatic segmentation, and cortical parcellation, respectively. Morel-Th is the reconstructed template image of Morel histological thalamic atlas, and MNI-VmPFC is the atlas for ventromedial prefrontal cortex of the Montreal Neurological Institute*.

Correlation Analysis With Clinical Scores
-----------------------------------------

We selected ROI pairs with significant group difference in their RSFC, and then performed a linear regression analysis to find correlations between functional connectivity of those selected ROI pairs and the seizure frequency for mTLE patients. *R*^2^ values were obtained by the linear regression function of MATLAB (version 2016a, The MathWorks, Inc., Natick, MA.).

Results {#s3}
=======

Functional Connectivity Difference Between mTLE and Healthy Control Groups
--------------------------------------------------------------------------

A total of 253 connections between ROI pairs were considered for group comparisons, and significant connectivity at the threshold level of p~FWE−corrected~ \< 0.001 was observed in 17 and 13% of the total ROI pairs in the healthy control and mTLE group, respectively ([Figures 1A,B](#F1){ref-type="fig"}). The mTLE patients showed decreased functional connectivity in the 17 ROI pairs of the limbic system, relative to the healthy control group, by a two-sample *t*-test with the default threshold level of the NBS tool (p~FWE−corrected~ \< 0.01). Specifically, the mTLE groups showed diminished intra-limbic connectivity between ipsilateral hippocampus, subiculum, hypothalamus, mediodorsal thalamus, ventromedial prefrontal cortex (BA14), bilateral parahippocampal gyri, ventral anterior, dorsal and ventral posterior cingulate cortices, and contralateral dorsal anterior cingulate cortex ([Figures 1C](#F1){ref-type="fig"}). The functional connectivity between limbic structures and temporal lobe regions showed less change compared to intra-limbic connectivity changes.

Correlations Between RSFC and Clinical Scores
---------------------------------------------

Two out of 17 limbic ROI pairs, had a significant correlation between their RSFCs and seizure frequency at the threshold level of *p* \< 0.05: ipsilateral ventral anterior cingulate cortex and hypothalamus (*R*^2^ = 0.391, *p* = 0.030) and ipsilateral subiculum and contralateral ventral posterior cingulate cortex (*R*^2^ = 0.362, *p* = 0.039) ([Figure 1C](#F1){ref-type="fig"}). The results of group comparisons and their correlation with seizure frequency are summarized in the [Table 4](#T4){ref-type="table"} and [Figure 1D](#F1){ref-type="fig"}.

###### 

The ROI pairs (circles) in limbic system, showing significant difference in functional connectivity between mTLE and HC groups.

  **Node pair**                           ***t*-value**                                           ***p*-value (two-tailed)**   **Correlation with seizure frequency**   
  --------------------------------------- ------------------------------------------------------- ---------------------------- ---------------------------------------- -----------------------------
  Hippocampus (ipsilateral)               \- vACC (contralateral)                                 −5.60                        \< 0.0001                                Not significant
                                          \- vPCC (ipsilateral)                                   −5.46                        \< 0.0001                                Not significant
                                          \- vPCC (contralateral)                                 −5.37                        \< 0.0001                                Not significant
                                          \- dPCC (ipsilateral)                                   −6.41                        \< 0.0001                                Not significant
                                          \- dPCC (contralateral)                                 −4.11                        0.0005                                   Not significant
                                          \- Ventromedial prefrontal cortex (BA14, ipsilateral)   −3.96                        0.0007                                   Not significant
                                          \- Parahippocampal gyrus (contralateral)                −3.30                        0.0033                                   Not significant
  Subiculum (ipsilateral)                 \- vACC (contralateral)                                 −3.64                        0.0014                                   Not significant
                                          \- vPCC (ipsilateral)                                   −3.65                        0.0014                                   Not significant
                                          \- vPCC (contralateral)                                 −3.77                        0.0011                                   *R^2^* = 0.391, *p* = 0.030
                                          \- dPCC (ipsilateral)                                   −4.31                        0.0003                                   Not significant
  Hypothalamus (ipsilateral)              \- vACC (ipsilateral)                                   −3.72                        0.0012                                   *R^2^* = 0.362, *p* = 0.039
                                          \- dACC (contralateral)                                 −3.67                        0.0013                                   Not significant
  Mediodorsal Thalamus (ipsilateral)      \- dACC (contralateral)                                 −3.94                        0.0007                                   Not significant
  Parahippocampal gyrus (ipsilateral)     \- vACC (contralateral)                                 −3.11                        0.0051                                   Not significant
                                          \- dACC (contralateral)                                 −4.82                        \< 0.0001                                Not significant
  Parahippocampal gyrus (contralateral)   \- vACC (contralateral)                                 −3.36                        0.0028                                   Not significant

Discussion {#s4}
==========

In this study, we compared RS FC in patients with mTLE and healthy controls. Using network-based statistics, we identified connectivity changes associated with mTLE and with seizure frequency in mTLE. RS FC within the limbic system decreased in mTLE, more so than limbic---temporal connectivity. These network abnormalities primarily affected the hemisphere ipsilateral to the seizure focus. Seizure frequency correlated with RS FC between ipsilateral hypothalamus and ventral anterior cingulate cortex and between ipsilateral subiculum and contralateral posterior cingulate cortex.

Our findings are consistent with the observed decrease in functional connectivity between limbic areas in mTLE patients, which is particularly pronounced in the hemisphere ipsilateral to the seizure focus ([@B22], [@B23]). It is possible that the decrease in functional connectivity reflects underlying limbic pathology in the mTLE group through hypothalamus-to-mediodorsal-thalamus and hippocampus/subiculum-to-cingulate-cortex pathways ([@B24], [@B25]). These changes would be consistent with the affective, memory, and cognitive/behavioral symptoms experienced by mTLE patients ([@B2]).

It is also possible that the decrease in limbic RS FC is compensatory. It may be speculated that decreasing functional connectivity ipsilateral to the seizure focus helps limit the participation of the abnormal temporal lobe in limbic circuitry, thereby preserving some measure of normal limbic function. The findings reported here for FMRI connectivity are consistent with studies using intracranial electrocorticography, which show that brain regions generating seizures are functionally isolated from surrounding brain regions ([@B26], [@B27]).

It is unclear why connectivity pairs in the cingulate cortex and hypothalamus and in the cingulate cortex and subiculum emerged as associated with seizure frequency. Previous network studies have focused on the clinical outcome of seizure freedom and not seizure frequency. One study of seizure propagation networks showed that seizure freedom associated with decreased functional connectivity in bilateral midline structures including the precuneus and midcingulate ([@B28]). This finding, together with our observation that select cingulate connectivity features are associated with seizure frequency, may implicate midline connectivity as an overall indicator of limbic network health. Importantly, without larger studies pooling subjects with similar disease courses, this proposal is purely speculative.

With the limbic system acting as a centerpoint for a range of cognitive and seizure-related processes, broader network changes may help explain the role of specific limbic regions in epilepsy ([@B29]). A pilot study of functional connectivity in deep brain stimulation (DBS) for epilepsy has suggested that patients who respond to DBS at the anterior nucleus of the thalamus have increased thalamic connectivity to the DMN ([@B30]). Intrinsic DMN connectivity increases prior to inter-ictal epileptiform discharges in TLE before returning to its baseline, decreased connectivity after the discharge ([@B31]). Further study of how paired connectivity features interact with other resting-state functional networks is warranted.

The primary limitation of this study was the small sample size. We did not conduct structured psychiatric interviews for this study and only retrospectively collected psychiatric histories from the medical record. Future efforts building on the present work will include prospective and comprehensive structured psychiatric assessments. A deeper understanding of the cause and nature of limbic connectivity in patients with mTLE may prove important in treating mTLE and the comorbidities associated with limbic network dysfunction. Also, we flipped the EPI data for left-handed subjects, but there are reports showing that mTLE patients have different behaviors regarding to the anatomical and functional features on the laterality ([@B32]--[@B34]). To observe more details on the laterality of mTLE connectivity, the further investigation with larger cohorts is required.

In conclusion, we identified functional connectivity changes associated with mTLE and cingulate and limbic network connectivity abnormalities that correlated with increased seizure frequency.
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